探讨心房颤动合并冠心病抗栓策略的研究进展  

Research Progress on Antithrombotic Strategy of Atrial Fibrillation Combined with Coronary Heart Disease

作　　者：张先位[1] ZHANG Xian-wei(Guangxi Zhuang Autonomous Region Minzu Hospital, Nanning Guangxi 530001)

机构地区：[1]广西壮族自治区民族医院,广西南宁530001

出　　处：《世界最新医学信息文摘》2018年第15期37-38,共2页World Latest Medicine Information Electronic Version

摘　　要：心房颤动是一种临床常见的快心室率型心律失常,其发生率与年龄增长呈正相关,且多与冠心病合并出现,危险性增加。临床治疗中以预防缺血性卒中为主要原则,研究发现冠状动脉内血栓形成机制与房颤血栓形成机制不同,临床抗血栓治疗方案亦需相应调整,但对于如何选择最佳抗栓治疗方案,在现阶段临床仍无统一标准。本次研究对此展开综述分析,旨意为房颤合并冠心病患者的临床抗栓治疗提供参考。Atrial fibrillation is a kind of common clinical arrhythmia of fast ventricular rate, whose incidence is positively correlated with growth. It is often associated with coronary heart disease with increasing risks. Main principle is ischemic stroke prevention in clinical treatment, and study showed mechanism of intravascular thrombus is different from atrial fibrillation thrombus, and clinical antithrombotic therapy should also be adjusted accordingly. However, is there is no unified clinical standard for choice of the best antithrombotic treatment at current stage. The study reveiws and analyzes the issue to provide reference for clinical antithrombotic treatment of atrial fibrillation and coronary heart disease patients.

关 键 词：心房颤动 冠心病 抗栓策略 研究进展 

分 类 号：R541.4[医药卫生—心血管疾病]